# OnCo record samuraciclib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/samuraciclib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "samuraciclib" ;
  schema:name "Samuraciclib"@en ;
  schema:alternateName "ICEC0942"@en, "CT7001"@en ;
  schema:description "Samuraciclib is an oral cdk inhibitor from Pfizer, in registered phase 2 trials for metastatic cancer, HR-positive / HER2-negative breast cancer."@en ;
  schema:url <https://onco.cc/drugs/samuraciclib/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=Samuraciclib> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest", "registry-only" ;
  onco:modality "Oral CDK inhibitor" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:companies <https://onco.cc/companies/pfizer/>, <https://onco.cc/companies/flatiron-health/> ;
  onco:trials <https://onco.cc/trials/nct06125522/>, <https://onco.cc/trials/nct04802759/> .